Treatment for the endocrine resistant breast cancer: Current options and future perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment for the endocrine resistant breast cancer: Current options and future perspectives

Published:2017-09 Issue: Volume:172 Page:166-175
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Liu Chun-Yu,Wu Chia-Yun,Petrossian Karineh,Huang Tzu-Ting,Tseng Ling-Ming,Chen Shiuan

Funder

Ministry of Science and Technology, Taiwan

Ministry of Health and Welfare, Executive Yuan, Taiwan

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference144 articles.

1. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database;Anderson;Breast Cancer Res. Treat.,2002

2. Metabolomic profiling of hormone-dependent cancers: a bird's eye view;Lloyd;ABBV Trends Endocrinol. Metab.,2015

3. Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer;Anbalagan;Mol. Cell. Endocrinol.,2015

4. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application;Hayashi;Endocr. Relat. Cancer,2003

5. Estrogen receptors in breast carcinogenesis and endocrine therapy;Huang;Mol. Cell. Endocrinol.,2015

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Significance of Thyroid Hormone Receptors in Breast Cancer: A Hypothesis-Generating Narrative Review;Current Oncology;2024-04-23

2. Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers;Drug Resistance Updates;2024-03

3. Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells;Medical Oncology;2024-01-17

4. Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase;ACS Pharmacology & Translational Science;2023-11-23

5. Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer;Pharmaceuticals;2023-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3